Percutaneous tracheostomy in patients with severe liver disease and a high incidence of refractory coagulopathy: a prospective trial

Table 1 Baseline characteristics

	All	Coagulopathy (n = 25)	Mild or no coagulopathy (n = 35)	P value
Age in years	42 (16–80)	42 (16–80)	34 (16–63)	0.002^a
Aetiology
Acute liver failure	25 (42%)	10 (40%)	15 (43%)
Chronic liver disease	19 (32%)	9 (36%)	10 (29%)
Post-transplant	9 (15%)	5 (20%)	4 (11%)
Other	7 (12%)	1 (4%)	6 (17%)
Severity of disease
APACHE II score	19 (4–30)	20 (9–28)	19 (4–30)
SOFA score	13 (3–22)	14 (10–22)	12 (3–18)	0.002^a
Duration of mechanical ventilation
Duration of CMV^b	7 (0–22)	7 (0–19)	6 (1–22)
Tracheostomy method
Blue Rhino^®	43	17	26

Values are presented as median (and range or percentage). ^a p < 0.05 significant. ^bDuration of controlled mechanical ventilation in days prior to procedure. APACHE II, Acute Physiology and Chronic Health Evaluation II; SOFA, Sepsis-related Organ Failure Assessment.

ISSN: 1364-8535